Various models - Electrode/lead, stimulator, implantable, neurological
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
19-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Abbott Medical Australia Pty Ltd
Class:
Class III
Manufactured by:
St Jude Medical 6901 Preston Road, Plano, Texas, 75024 United States Of America
Therapeutic area:
44040 - Neural-tissue electrical stimulation lead
Therapeutic indications:
ANS Lamitrode S-Series (S4 and S8) Leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. Lamitrode S-Series Leads are intended to be used with Advanced Neuromodulation System?s IPGs, receivers, transmitters, patient programmers, and extensions.
Authorization status:
A
Authorization date:
2006-03-08
